
“For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law. According to a just published review in the German scientific journal Deutsches Ärzteblatt International, scientific findings from over 100 controlled clinical trials involving either cannabis or its constituents provide ‘clear evidence that cannabinoids are useful for the treatment of various medical conditions.'”
Related posts:
6 Red States That Are Turning Green at a Rapid Clip
Spanish real estate is where to invest, say Soros and Paulson
Sheriff Indicted For Locking Down Entire School, Sexually Assaulting Kids
The history of the requirement that U.S. citizens use U.S. passports to travel
US Government Moves To Seize 139-Year-Old Family Gold Mines
Upturn Millionaires: How to Play the Turning Tides in Precious Metals
Tesla is losing over $4,000 on each car it sells
The Torture State's Latest Victory
Why We're Not Sneering at the Averages
The Best Mob Story Ever
Senate Votes To Turn NSA Spying Back On, But With Reforms
Google Launches Same-Day Delivery in San Francisco Bay Area
Poll suggests win for initiative repealing Michigan’s emergency managers law
Local Perceptions and Bitcoin’s Future in Singapore
German Central Bank Official Issues Another Bitcoin Warning